<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Noget nyere om det omtalte CORAL kan for eksempel findes her: http:&#x2F;&#x2F;www.asco.org&#x2F;ascov2&#x2F;Meetings&#x2F;Abstracts?&amp;vmview=abst_detail_view&amp;confID=65&amp;abstractID=30637]]></title><description><![CDATA[<p dir="auto">Noget nyere om det omtalte CORAL kan for eksempel findes her: <a href="http://www.asco.org/ascov2/Meetings/Abstracts?&amp;vmview=abst_detail_view&amp;confID=65&amp;abstractID=30637" rel="nofollow ugc">http://www.asco.org/ascov2/Meetings/Abstracts?&amp;vmview=abst_detail_view&amp;confID=65&amp;abstractID=30637</a></p>
<p dir="auto">Citat:"Patients with prior exposure to rituximab had more refractory disease and adverse prognostic factors."</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/448360/noget-nyere-om-det-omtalte-coral-kan-for-eksempel-findes-her-httpwwwascoorgascov2meetingsabstractsvmviewabst-detail-viewconfid65abstractid30637</link><generator>RSS for Node</generator><lastBuildDate>Sat, 20 Jun 2026 08:32:05 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/448360.rss" rel="self" type="application/rss+xml"/><pubDate>Sat, 06 Aug 2011 06:26:53 GMT</pubDate><ttl>60</ttl></channel></rss>